Weil Pharmaceutical announced that the company's share repurchase plan plans to use 50 million yuan to 10 million yuan of its own and self-funded funds to repurchase shares through centralized bidding for employee stock ownership plans or equity incentives. The repurchase price will not exceed 40.11 yuan/share, and the repurchase period will be from September 30, 2026 to September 29, 2027. As of November 12, 2026, the company had repurchased 2.7088 million shares, accounting for 2.00% of the total share capital. The repurchase price range was 25.58 yuan/share - 28.00 yuan/share, with a total payment capital of 72.6938 million yuan.

Weil Pharmaceutical announced that the company's share repurchase plan plans to use 50 million yuan to 10 million yuan of its own and self-funded funds to repurchase shares through centralized bidding for employee stock ownership plans or equity incentives. The repurchase price will not exceed 40.11 yuan/share, and the repurchase period will be from September 30, 2026 to September 29, 2027. As of November 12, 2026, the company had repurchased 2.7088 million shares, accounting for 2.00% of the total share capital. The repurchase price range was 25.58 yuan/share - 28.00 yuan/share, with a total payment capital of 72.6938 million yuan.